Alma appoints Eyal Ben David as CEO

Alma appointed Eyal Ben David as chief executive officer and the Board of Sisram Medical named Lior Dayan chairman, a leadership change the organizations described as intended to support Alma's next phase of growth.

The board approved the appointments after eight years of Mixed Reality (MR). Dayan's leadership at Alma and Sisram Medical; the company reported revenue growth from USD 138 million to about USD 400 million during Healthcare Information System (HIS) tenure and said it served more than 110 countries and 46,000 clinics.

The company listed its offerings as energy-based device lasers, diagnostics, injectables, advanced skincare, personalized treatment systems, and other Energy-Based Devices (EBD) technologies.

Following the board decision, MR. Eyal Ben David, a 16-year employee and former president of international markets, assumed the role of chief executive officer of Alma, and MR. Jiahong Li expanded responsibilities as Alma's co‑CEO. MR. Keith Adams moved into the chairman role at Alma Inc. and into senior vice president responsibilities for Sisram's corporate development, and MR. Spencer Detter became acting general manager of Alma Inc.

“Lior Dayan has been an exceptional leader and visionary,” said Chairman Liu Yi. “He transformed the company into a category-defining global brand and built the foundation for long-term strategic expansion. As Chairman of Sisram, his insight and experience will be invaluable as we continue to execute our global strategy.”

The release said Chairman Liu expressed confidence the new board and leadership team would further strengthen Alma's global position through strategic growth, and MR. Dayan said he expected them to build on Alma's foundation, with collaboration, technological advancement, and sustained growth.